SULFAMETHOXAZOLE AND TRIMETHOPRIM

Post-LOE

sulfamethoxazole and trimethoprim

KalVista Pharmaceuticals
ANDAORALTABLET
Approved
Oct 2005
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

Dihydrofolate Reductase Inhibitors

Pharmacologic Class:

Dihydrofolate Reductase Inhibitor Antibacterial

Company
KalVista Pharmaceuticals
KalVista Pharmaceuticals
FRAMINGHAM, MA
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers